Innovent Biologics Inc. (HKEX: 1801) announced that its psoriasis treatment PECONDLE achieved primary and key secondary endpoints in a phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE